MOTS-c, a mitochondrial derived peptide (MDP), is a ground-breaking human peptide that offers a variety of physiological benefits. It not only improves insulin sensitivity but also promotes the biosynthesis of endogenous AMP analogue, AICAR, giving a robust response by activating protein kinase. This peptide holds significant potential in the therapeutic and research ecosystems with its unique ability to enhance metabolic activities and deliver anti-aging results.
MOTS-c increases glucose uptake in cells, making it a potent candidate as a weight-loss peptide raw material. It also imparts substantial anti-aging effects, making it highly valuable in the cosmetic and health industries. As a research-grade product, you can rely on MOTS-c for accuracy, effectiveness, and consistency across diverse applications.
MOTS-c is available in varied packaging options such as 500mg, 1g, 10g, 50g, and 100g, catering to different operational scales. Discover the potential of MOTS-c and spearhead path-breaking advancements for healthcare and cosmetic industries.